The present invention provides compounds of Formula I,
1
including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R
2
, and R
3
are defined as described herein.
本发明提供了公式I的化合物,包括其药学上可接受的盐和/或前药,其中G、R2和R3的定义如本文所述。
Method of treating transplant rejection
申请人:Waegell Wendy
公开号:US20050008640A1
公开(公告)日:2005-01-13
This invention relates to a method of treating transplant rejection comprising administering to a patient a pharmaceutical composition comprising an lck inhibitor and a calcineurin inhibitor or an immunosuppressant.